Clinical I V Network LLC is categorized under Home Health Care Services in Pawtucket, RI and active since 1987.
Clinical I V Network LLC was established in 1987, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 621610 by the NAICS.
If you are seeking more information, feel free to contact Donna Woodmansee at the company’s single location by writing to 15 Hazel St, Pawtucket, Rhode Island RI 02860 or by phoning (401) 727-6100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical I V Network LLC |
| Contact Person: | Donna Woodmansee |
| Address: | 15 Hazel St, Pawtucket, Rhode Island 02860 |
| Phone Number: | (401) 727-6100 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1987 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 621610 |
| Share This Business: |
Clinical I V Network LLC was started in 1987 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 621610. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Donna Woodmansee for inquiries that concern Clinical I V Network LLC by calling the company number (401) 727-6100, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical I V Network LLC can be found at the coordinates 41.878076,-71.408702 as well as the street address 15 Hazel St in Pawtucket, Rhode Island 02860.
For its online presence, you may visit Clinical I V Network LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.